Novian Health

  • About Us
    • Overview
    • Management
    • Board Of Directors
    • Investors
  • Research & Products
    • Novilase® Breast Therapy
    • Clinical Trials & Registries
    • Publications
    • Intellectual Property
  • News
    • News & Press Releases
    • Media Coverage
    • Upcoming Events
  • Contact
    • Careers

Novian Health Announces Agreement with Tower Radiology Center in Tampa Bay

November 18, 2009 by Novian Health

November 18, 2009
Contact: Liz Dowling, (800) 386-0157
Dowling & Dennis Public Relations
E-mail:Liz@DowlingDennis.net

Novian Health Announces Agreement with Tower Radiology Center in Tampa Bay Leading radiology practice offers Novilase™ to treat breast lumps CHICAGO – Novian Health, manufacturer of Novilase™ Breast Therapy for benign breast tumors, announced an agreement with Tower Radiology Center to provide the Novilase laser treatment to treat benign breast lumps.

“Benign breast lumps are common and women often want them removed because even though the tumors are benign, they associate them with breast cancer symptoms,”said Miguel Del Toro, M.D., a radiologist at Tower Radiology. “Until recently, benign breast tumors were usually removed by surgeons. The Novilase procedure is a valuable addition to radiologists’ toolkit, and the procedure will be even more valuable if and when it becomes available to remove cancerous breast tumors.”

Novilase is a minimally invasive procedure that uses heat from a laser to destroy benign breast tumors, (e.g., fibroadenomas). These breast lumps appear most often in premenopausal women. Novilase, an alternative to surgical removal, is safe, effective,and less risky than surgery while providing a superior cosmetic outcome. Novilase is FDA-cleared for this indication and is not an experimental procedure.

The procedure is performed using local anesthetic via two small probes inserted through tiny nicks in the skin. Only targeted tissue is destroyed. After the treatment, the nicks are covered with an adhesive bandage and do not require sutures as with surgery. The body’s natural healing process repairs the site by replacing ablated tissue
with healthy tissue.

Tower Radiology Center is also participating in the American Breast Laser Ablation Therapy Evaluation (ABLATE) data collection program, to gather further clinical information about Novilase.

The Tower agreement is one of several similar agreements being announced by Novian Health this year.

“As Tower Radiology is demonstrating, Novilase can be integrated into a radiology practice to offer patients a minimally invasive treatment alternative” said Henry R. Appelbaum, Novian Health’s President and CEO. “We invite any radiologist in Chicago for the RSNA annual conference to contact us at our Chicago headquarters while they’re here. We would be happy to provide information about Novilase and arrange a demonstration of the procedure for them.”

About Tower Radiology Center

Tower Imaging, Inc. ‘dba’ Tower Radiology Center, is Tampa Bay’s largest physician owned and operated outpatient radiology practice. Tower’s highly trained board-certified sub-specialty radiologists provide unparalleled experience in outpatient diagnostic radiology, with specific training in neuroradiology, musculoskeletal, nuclear
medicine, cardiothoracic imaging, women’s imaging, pediatric radiology and vascular & interventional radiology. In addition to Tower’s commitment to provide the community with the highest level of quality in diagnostic radiology, Tower radiologists participate in research and teaching as voluntary faculty with University of South Florida College of Medicine, Department of Radiology. For more information, call (813) 24-TOWER or access www.towerdiagnostic.com/womensimaging .

About Novian Health

Novian Health Inc., located in Chicago, is a privately held company with proprietary technology for the treatment of tumors using Interstitial Laser Therapy (ILT).The company’s minimally invasive Novilase procedure uses ILT (controlled heating) for the ablation of breast tumors as an alternative to the surgically invasive, traditional “lumpectomy.”
Novian Health received its first FDA 510(k) market clearance for treating fibroadenomas (benign tumors) of the breast and expects to offer its technology at centers around the country. Approval for treatment of malignant tumors will also be sought. Formore information, call (312) 266-7200 or access www.novianhealth.com.

Related Posts

  • Novian Health Announces Agreement with Rose Medical Center in Denver
  • Novian Health Presents at William Blair Private Conference
  • Novian Health Awarded New Patent for Breast Cancer Treatment Technology (05 Dec 2013)
  • Novian Health Presents at the “2nd Annual Venture Connections: A Frost & Sullivan Executive Symposium
  • Novian Health Receives FDA Approval to Study Breast Cancer Therapy (14 July 2011)

Filed Under: Archives

Recent Posts

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

ARCHIVES

  • December 2022
  • September 2021
  • August 2021
  • July 2021
  • February 2021
  • September 2020
  • June 2020
  • September 2019
  • July 2019
  • June 2019
  • December 2015
  • December 2014
  • September 2014
  • May 2014
  • December 2013
  • April 2013
  • February 2013
  • April 2012
  • October 2011
  • September 2011
  • July 2011
  • November 2010
  • December 2009
  • November 2009
  • October 2009
  • May 2009
  • June 2008
  • March 2008
  • October 2007
  • June 2007

Categories

  • Archives
  • Press Release 2011
  • Press Release 2012
  • Press Release 2013
  • Press Release 2014
  • Press Release 2015
  • Press Release 2019
  • Press Release 2020
  • Press Release 2021
  • Press Release 2022

CONTACT US

Novian Health Inc.
(Headquarters)
Novian Health Inc.
(Manufacturing)
222 W Merchandise Mart Plaza
Suite 1230
Chicago, Illinois 60654
1205 E State Avenue
Tonganoxie, KS 66086
Office: 312-266-7200 Office: 312-266-7200
Fax: 312-266-7202 Fax: 312-266-7202
Email: info@novianhealth.com Email: info@novianhealth.com

    

LATEST NEWS

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

Copyright © 2023 Novian Health. All Rights Reserved. Powered by